STOCK TITAN

Clarivate Plc Stock Price, News & Analysis

CLVT NYSE

Welcome to our dedicated page for Clarivate Plc news (Ticker: CLVT), a resource for investors and traders seeking the latest updates and insights on Clarivate Plc stock.

Clarivate Plc (NYSE: CLVT) delivers transformative intelligence through market-leading platforms like Web of Science™ and Cortellis™, powering innovation across academia, intellectual property, and life sciences. This news hub provides investors and professionals with direct access to official announcements shaping global research and commercialization efforts.

Track critical updates including quarterly earnings disclosures, strategic partnerships, product launches, and regulatory filings. Our curated feed ensures timely access to press releases about AI-driven analytics advancements, IP portfolio developments, and expansions in pharmaceutical intelligence solutions.

Key content categories include financial performance reports, acquisition announcements, leadership updates, and innovations in real-world data applications. Bookmark this page to monitor Clarivate's progress in converting transactional revenues to high-margin subscriptions while maintaining its position as a critical enabler of R&D workflows.

Rhea-AI Summary

Clarivate (NYSE:CLVT) has launched two new AI-powered solutions for its Innography platform: AI Classifier and SEP Analyzer. The AI Classifier achieves up to 97% first-pass accuracy in patent classification and can reduce classification time from weeks to minutes, leveraging supervised machine learning and large language models (LLMs).

The SEP Analyzer focuses on streamlining standard essential patent research by providing normalized data and clear visualizations for licensing negotiations. Both tools are designed to enhance patent portfolio management and strategic decision-making capabilities for Innography customers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.31%
Tags
-
Rhea-AI Summary

Clarivate (NYSE:CLVT) has announced its 2025 Citation Laureates, recognizing 22 researchers whose work demonstrates Nobel-class influence. The program, which has successfully identified 83 eventual Nobel Prize winners since its inception, uses Web of Science citation data to select researchers from an elite group representing less than 0.02% of over 64 million indexed publications.

This year's cohort includes researchers from eight countries, with a historic first Citation Laureate from Mainland China, Professor Tao Zhang, recognized for pioneering single-atom catalysis. The laureates' research spans critical fields including leukemia treatment, quantum computing, energy storage, and economic inequality, with ten based in the United States and others across Europe and Asia.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.44%
Tags
none
-
Rhea-AI Summary

Clarivate (NYSE:CLVT) has released its 2024 sustainability report, highlighting significant achievements in advancing UN Sustainable Development Goals (SDGs). The company reported that 49% of its revenue is directly aligned with SDGs, while its solutions benefit over 130 million students and serve more than 26,000 public and academic libraries.

Key highlights include the signing of the UN SDGs Publishers Compact, the launch of a Sustainability Ebook Subscription, and the contribution of 32,000 collective volunteer hours by employees. The company maintains commitments to the UN Global Compact, Women's Empowerment Principles, and CEO Action for Inclusion & Diversity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.49%
Tags
none
Rhea-AI Summary

Clarivate (NYSE:CLVT), a global provider of transformative intelligence, has announced that Jonathan Collins, Executive Vice President and Chief Financial Officer, will present at the upcoming Goldman Sachs Communacopia + Technology Conference.

The presentation is scheduled for September 11, 2025, at 8:50 AM Pacific Time (11:50 AM Eastern Time). Investors can access the live webcast through the provided link, and a replay will be available on Clarivate's investor relations website for 90 days following the presentation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.41%
Tags
conferences
-
Rhea-AI Summary

Clarivate (NYSE:CLVT) has entered into a strategic partnership with Sinopec Group, China's largest oil and petrochemical products supplier, to provide academic research and intellectual property solutions. The collaboration includes access to the Web of Science platform and incoPat global patent data, covering over 200 million records from 172 countries.

Through this partnership, Sinopec Group will leverage Clarivate's comprehensive data insights and expert services to enhance its research and development capabilities, particularly in low-carbon energy and environment-friendly materials. The agreement builds upon an existing relationship where Sinopec Group already utilizes other Clarivate solutions including InCites Benchmarking & Analytics, Derwent Innovation, and Darts-ip.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.22%
Tags
none
-
Rhea-AI Summary

Clarivate (NYSE:CLVT) has entered into a partnership with the University of Melbourne to provide comprehensive library solutions and services. The collaboration includes implementing Alma, Primo, Leganto, Rapido, and Library Open Workflows platforms to enhance library management systems and resource discovery.

The partnership aims to deliver a world-class library systems platform that integrates academic AI and linked data to improve teaching, learning, and research capabilities. The Alma platform, currently used by over 2,700 libraries worldwide, will help streamline operations and enhance data-driven decision-making at Australia's leading university.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
partnership
Rhea-AI Summary

Clarivate (NYSE:CLVT) has announced the beta launch of its AI-powered Regulatory Assistant within the Cortellis Regulatory Intelligence platform. The new tool, set for full release in September, aims to help regulatory professionals in biopharma, medtech, and research organizations navigate complex global requirements more efficiently.

The AI Assistant features include conversational AI with referenced answers, chat history functionality, and multilingual capabilities. The solution has been developed with input from industry partners, including Moderna, and builds on Clarivate's 30+ years of regulatory expertise and proven AI platform that powers other solutions like Web of Science.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.17%
Tags
AI
-
Rhea-AI Summary

Clarivate (NYSE:CLVT), a global provider of transformative intelligence, has announced its participation in the upcoming Oppenheimer 28th Annual Technology, Internet & Communications Virtual Conference. CEO Matti Shem Tov and CFO Jonathan Collins will present on August 13, 2025, at 12:25 PM ET.

The presentation will be accessible via live webcast, with replay options available on the company's investor relations website for 90 days following the event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.31%
Tags
conferences
-
Rhea-AI Summary

Clarivate (NYSE:CLVT) has appointed Maroun S. Mourad as President of its Intellectual Property segment, effective September 8, 2025. Mourad, who previously served as President of Claims Solutions at Verisk Analytics, succeeds Gordon Samson, who will retire at the end of 2025.

Mourad brings extensive experience in data analytics and software, having grown businesses across the U.S., U.K., Europe, and emerging markets since 1998. He holds a BA in political science and a JD from UC Berkeley. The appointment aligns with Clarivate's strategy to drive long-term predictable growth in its IP business, which provides IP data, software, and expertise for innovation management and IP asset protection.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.26%
Tags
none
Rhea-AI Summary

Clarivate (NYSE:CLVT) reported Q2 2025 results with total revenues of $621.4 million, down from $650.3 million in Q2 2024 due to divestitures. The company showed positive trends with organic revenue growth of 0.5% and organic ACV growth of 1.3%. Notably, organic recurring revenue mix improved to 88%, up 800 basis points from year-end 2024.

Q2 2025 net loss was $72.0 million ($0.11 per share), improving from a $304.3 million loss in Q2 2024. Adjusted EBITDA reached $261.6 million. The company generated $287.5 million in operating cash flow and repurchased 11.5 million shares in Q2. Management reaffirmed its 2025 outlook, projecting revenues of $2.28B-$2.40B and adjusted EBITDA of $940M-$1.00B.

[ "Organic revenue growth of 0.5% and organic ACV growth of 1.3%", "Improved recurring revenue mix to 88%, up 800 basis points from 2024", "Net loss improved significantly to $72.0M from $304.3M in Q2 2024", "Generated strong operating cash flow of $287.5M in H1 2025", "Executed share repurchase of 23.2M shares at average price of $4.29" ]
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.26%
Tags

FAQ

What is the current stock price of Clarivate Plc (CLVT)?

The current stock price of Clarivate Plc (CLVT) is $3.89 as of October 3, 2025.

What is the market cap of Clarivate Plc (CLVT)?

The market cap of Clarivate Plc (CLVT) is approximately 2.5B.
Clarivate Plc

NYSE:CLVT

CLVT Rankings

CLVT Stock Data

2.54B
351.58M
16.66%
89.99%
5.72%
Information Technology Services
Services-computer Processing & Data Preparation
Link
United Kingdom
ST. HELIER